After many years of focused research, an innovative vaccine candidate may become available in 2023 to combat the chikungunya virus, which has spread to over 120 countries.
Chikungunya is a mosquito-borne viral disease caused by the chikungunya virus (CHIKV) transmitted to humans by a bite from Aedes mosquitoes.
The U.S. CDC says a CHIKV infection leads to symptomatic disease in 72-92% of humans after a few days.
While mortality is low, CHIKV morbidity is high.
This disease can impact over 30% of the population in areas where CHIKV is circulating.
Read More
